KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Exelixis (EXEL) EBT Margin (2016 - 2026)

Exelixis (EXEL) has 16 years of EBT Margin data on record, last reported at 42.21% in Q1 2026.

  • For Q1 2026, EBT Margin rose 961.0% year-over-year to 42.21%; the TTM value through Jan 2026 reached 40.57%, up 914.0%, while the annual FY2026 figure was 40.57%, 914.0% up from the prior year.
  • EBT Margin reached 42.21% in Q1 2026 per EXEL's latest filing, roughly flat from 42.23% in the prior quarter.
  • Across five years, EBT Margin topped out at 45.96% in Q2 2024 and bottomed at 7.41% in Q4 2022.
  • Average EBT Margin over 5 years is 24.8%, with a median of 23.15% recorded in 2022.
  • Peak YoY movement for EBT Margin: crashed -3357bps in 2022, then soared 2890bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 7.41% in 2022, then surged by 390bps to 21.48% in 2023, then surged by 34bps to 28.68% in 2024, then skyrocketed by 47bps to 42.23% in 2025, then decreased by 0bps to 42.21% in 2026.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 42.21% in Q1 2026, 42.23% in Q4 2025, and 40.55% in Q3 2025.